Tag: prostate cancer

The brain makes upward of 35,000 decisions a day, and few weigh as heavily as choosing a prostate cancer treatment. When a biopsy hints at a riskier cancer, genomic testing of the tissue can settle the question. A reassuring result gives men real confidence in Active Surveillance or focal therapy, and new 2026 research shows what a high score can warn about. keep reading

What’s every man’s least favorite medical exam? For many, it’s the digital rectal exam, sometimes called the urologist’s handshake. Beyond the discomfort, the exam can only reach one surface of the prostate and misses most tumors. Now a 2026 study of more than 4,000 men suggests MRI-based staging can replace it without losing accuracy. keep reading

Here's an uncomfortable truth: most elevated PSA tests turn out to be false alarms, yet they still steer hundreds of thousands of men toward a needle biopsy every year. A smarter path exists. By adding the Stockholm3 blood test and an MRI before anyone reaches for a needle, doctors can tell which men genuinely need a biopsy and which can safely wait, sparing a lot of worry and harm. keep reading

Prostate cancer has a reputation as an older man's diagnosis, yet a growing number of men in their 20s, 30s, and 40s are hearing it too. Inherited gene mutations, missed early symptoms, and lifestyle factors all feed the trend, and younger patients often face later-stage disease. Early PSA testing paired with MRI offers a powerful way to catch trouble sooner. keep reading

Could saying "I do" actually help a man live longer? When it comes to prostate cancer, the research is surprisingly consistent across decades. Married patients tend to be diagnosed earlier and survive longer than their unmarried peers, and new data now suggests the protective effect of marriage may extend to lowering cancer risk in the first place. keep reading

For decades, men have faced a coin flip after a high PSA result: biopsy or nothing. A major study of nearly 18,000 men suggests there's a smarter middle step — MRI. Used as a filter between PSA and biopsy, it identifies who truly needs further evaluation and cuts unnecessary overtreatment in half. keep reading

Imagine seeing even clearer prostate images than today’s advanced 3T MRI allows—5T MRI could make that a reality. While research teams report remarkable image quality and better tumor visibility with 5T, economic and practical challenges mean that 3T MRI remains the standard for prostate cancer screening and treatment guidance. keep reading

Detecting prostate cancer early makes nearly 100% treatment success possible, often with fewer side effects. Routine PSA screening and modern imaging tools help identify cancer while it's still most curable. Skipping annual tests risks missing the critical window for best outcomes. keep reading

How can a simple blood test reveal silent cancer risks? Many men are surprised to learn early prostate cancer often shows no symptoms at all—making questions about warning signs, PSA screening, or family history even more important. Find out how age, genetics, and lifestyle shape the story, and why timing matters for peace of mind. keep reading

MRI-based diagnosis offers a more accurate and less invasive path for prostate cancer detection than traditional methods. By identifying clinically significant tumors before biopsy, the MRI pathway helps prevent overtreatment while safeguarding quality of life. keep reading